["{\"step_by_step_thinking\": \"The question is asking about a Rh-negative mother who received Anti-D during 28 weeks of pregnancy and had an ICT negative result. This indicates that she did not develop immunity to the Rh factor. Therefore, there is no need for additional doses of Anti-D. The information provided in the documents does not suggest any specific timing or group-based dosing. Hence, options A and B are not relevant. Option C suggests that the mother does not require additional doses since her ICT result was negative, which aligns with the available data.\", \"answer_choice\": \"C\"}"]